"10.1371_journal.pone.0082586","plos one","2013-12-20T00:00:00Z","Wen Li; Akico Okuda; Hideyuki Yamamoto; Kyosuke Yamanishi; Nobuyuki Terada; Hiromichi Yamanishi; Yoshimasa Tanaka; Haruki Okamura","Laboratory of Tumor Immunology and Cell Therapy, Hyogo College of Medicine, Hyogo, Japan; Department of Pathology, Hyogo College of Medicine, Hyogo, Japan; Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan; Hirakata General Hospital for Developmental Disorders, Hirakata, Osaka, Japan; Center for Innovation in Immunoregulative Technology and Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan","Conceived and designed the experiments: HO WL. Performed the experiments: WL AO KY NT H. Yamanishi YT. Analyzed the data: WL H. Yamamoto. Contributed reagents/materials/analysis tools: YT. Wrote the paper: HO WL. Revised the manuscript: NT YT. Discussions: HO WL AO H. Yamamoto KY NT H. Yamanishi YT.","The authors have read the journals policy and have the following conflicts: The study was funded in part by Astellas Pharma Inc. Recombinant human IL-18 and ZOL were kindly provided by GlaxoSmithKline plc (Research Triangle Park, NC) and Novartis AG (Basel, Switzerland), respectively. This does not alter the authors adherence to all PLOS ONE policies on sharing data and material.","2013","12","Wen Li","WL",8,TRUE,2,5,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
